Active Pharma Supplies

Executive Summary

Active Pharma Supplies (APS) is a UK-based specialist distributor of active pharmaceutical ingredients (APIs), excipients, and raw materials, serving hospitals, compounding pharmacies, pharmaceutical manufacturers, and veterinary clinics. Founded in 2005 and headquartered in London, APS positions itself as a value-added supply chain partner, offering services like repackaging and next-day delivery. The company focuses on providing regulatory-compliant, hard-to-source starting materials for small-batch and specials manufacturing, a niche that supports the growing demand for personalized medicine and specialized formulations. APS operates in the drug delivery ecosystem, catering to customers that require reliable, fast access to critical raw materials for production. As a private company with no disclosed funding or valuation, APS is a small but essential player in the pharmaceutical supply chain. Its conviction score reflects a stable business model dependent on recurring demand from regulated customers and the ongoing trend toward localized, small-batch manufacturing. Key catalysts include potential expansion of its product portfolio or partnerships with contract development and manufacturing organizations (CDMOs), as well as increased hospital outsourcing of compounding services. However, given the lack of public milestones or growth indicators, near-term visibility is limited.

Upcoming Catalysts (preview)

• Q4 2026Expansion into sterile compounding APIs or biologics excipients40% success
• Q2 2026New strategic partnership with a UK hospital network or CDMO55% success
• Q3 2026Regulatory approval for additional repackaging sites (MHRA)70% success